History of Charcot–Marie–Tooth disease

Charcot–Marie–Tooth disease, a hereditary disorder affecting the peripheral nerves, was formally identified and described in the late 19th century through collaborative and parallel investigations in France and England. The condition carries the names of three neurologists whose 1886 publications established it as a distinct clinical entity. Prior to their work, the slowly progressive muscle wasting and weakness it caused had been variously misclassified under broader categories of muscular and nervous disease.

Historical Narrative

Before the formal identification of Charcot–Marie–Tooth disease, physicians encountering patients with slowly progressive limb weakness and muscle wasting had few conceptual tools to distinguish among the many conditions that produced such findings. Ancient and medieval physicians attributed wasting of the limbs to a wide variety of causes, including humoral imbalances, cold and damp environments, and the malign influence of fevers. The concept of hereditary transmission of disease existed in ancient Greek thinking, as Hippocratic writers noted that certain family lines seemed prone to particular ailments, but a systematic understanding of how diseases could be passed through generations awaited centuries of further development.

By the early 19th century, European physicians had begun distinguishing between disorders primarily affecting the muscles themselves and disorders arising from damage to the nerves supplying those muscles. Guillaume Duchenne de Boulogne, working in Paris in the mid-19th century, pioneered the use of electrical stimulation to study muscle and nerve function, producing detailed clinical descriptions that helped separate several distinct neuromuscular conditions from one another. His methods and his insistence on precise clinical documentation directly influenced the next generation of French neurologists, including Jean-Martin Charcot.

Charcot, working at the Salpêtrière Hospital in Paris, became the dominant figure in 19th-century neurology. Together with his student Pierre Marie, Charcot published in 1886 a careful description of a familial condition characterized by slowly progressive weakness and wasting beginning in the lower legs and feet and eventually affecting the hands and forearms. They traced the condition across multiple generations in affected families, offering some of the earliest systematic evidence for its hereditary nature, and they distinguished it clearly from other progressive muscular diseases of the era.

In the same year of 1886, entirely independently, the British neurologist Howard Henry Tooth published his own description of the same condition as part of his Cambridge doctoral thesis. Tooth provided additional clinical detail and argued persuasively that the primary pathology lay in the peripheral nerves rather than the muscles themselves, a distinction that proved highly significant. The convergence of these two independent publications in a single year led subsequent physicians to honor all three investigators by combining their names in the condition's title.

In the decades following 1886, neurologists debated whether the disease primarily affected the nerve fibers themselves or the supporting myelin sheath surrounding them. Histological examination of nerve tissue from deceased patients gradually revealed that both forms existed, a distinction that became the basis for later classificatory efforts. Early 20th-century researchers, including those working in the emerging field of electrophysiology, developed methods for measuring nerve conduction that added a new investigative dimension to the study of hereditary neuropathies.

The hereditary nature of the condition attracted the interest of early geneticists, and by the mid-20th century, family pedigree analyses had confirmed patterns consistent with autosomal dominant inheritance in most affected kindreds. The condition came to be recognized as one of the most common inherited neurological disorders, a fact that spurred growing research interest throughout the latter half of the 20th century as molecular biology began offering new tools for investigating genetic diseases.

Key Historical Figures

• Jean-Martin Charcot
• Pierre Marie
• Howard Henry Tooth
• Guillaume Duchenne de Boulogne

Historical narrative only — this page describes how Charcot–Marie–Tooth disease was understood historically. It is not medical advice and does not describe current diagnosis or treatment. Sourced from verified medical history references (NIH, Encyclopaedia Britannica, and standard medical history texts). See our medical disclaimer.